Jay Lichter

Insider Reports History

Entity
Individual
Location
C/O Aratana Therapeutics, Inc., 11400 Tomahawk Creek Parkway, Suite 340, Leawood, KS
Signature
/s/ Maria Dobek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay Lichter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 3.34M $183M $54.75 Jun 26, 2024 By Avalon BioVentures SPV I, L.P.
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 3.27M $179M $54.75 Jun 26, 2024 By Avalon Ventures XI, L.P.
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 634K $34.7M $54.75 Jun 26, 2024 By Avalon BioVentures I, LP
Janux Therapeutics, Inc. Director, 10%+ Owner Common Stock 7.08K $388K $54.75 Jun 26, 2024 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K Jun 21, 2022 Direct
Janux Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 8.35K Jun 26, 2024 Direct

Insider Reports Filed by Jay Lichter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jun 26, 2024 2 $0 4 Jun 28, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 3, 2024 3 -$82.1M 4 Jun 5, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Nov 13, 2023 1 $4.99M 4 Nov 15, 2023 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director, 10%+ Owner
OTIC OTONOMY, INC. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
JANX Janux Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
OTIC OTONOMY, INC. Jun 22, 2021 1 $0 4 Jun 24, 2021 Director
JANX Janux Therapeutics, Inc. Jun 15, 2021 11 $10.7M 4 Jun 16, 2021 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Director, 10%+ Owner